While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...
TipRanks on MSN
InflaRx reveals phase 3 post‑hoc efficacy signals for vilobelimab in pyoderma gangrenosum after trial halt
InflaRx ( ($IFRX) ) has shared an announcement. On December 30, 2025, InflaRx reported detailed Phase 3 data analyses for vilobelimab in pyoderma ...
While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...
MedPage Today on MSN
First Drug for Deadly Transplant Complication Gets FDA's Blessing
The FDA has approved narsoplimab (Yartemlea) as the first treatment for hematopoietic stem cell transplant (HSCT)-associated ...
The Times of Israel on MSN
Defense Ministry hands IDF first combat-ready Iron Beam laser interception system
High-power aerial defense system has successfully intercepted rockets, mortars and drones in testing, is set to be absorbed ...
Nvidia’s stock gained about 40% this year, and the company set many new projects in motion that will keep the company at the ...
Super flu cases are surging, with symptoms including high fever, severe body aches, extreme fatigue, cough and lingering ...
The fundamental concept behind the new frigate is sound, and the Navy’s goal of having the first one built in three years may ...
January has a way of making food feel adversarial. Suddenly, every meal, snack, and night out is framed as a test of ...
Drone swarms are changing warfare, air defense, and civilian aviation. Here’s how coordinated drones work, fight, and play ...
Cancer is no longer considered untreatable, yet improving the accuracy and timeliness of diagnostics and treatment remains ...
To build the best ergonomic setup , the secret lies in choosing furniture series that complement one another. Eureka ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback